Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Clinical Application of $^{18}F-FDG$ PET and PET-CT in Adrenal Tumor

부신종양에서 $^{18}F-FDG$ PET 및 PET-CT의 임상 이용

  • Hwang, Kyung-Hoon (Department of Nuclear Medicine, Gachon University Gil Hospital) ;
  • Choi, Duck-Joo (Department of Internal Medicine, Gachon University Gil Hospital) ;
  • Lee, Min-Kyung (Department of Nuclear Medicine, Gachon University Gil Hospital) ;
  • Choe, Won-Sick (Department of Nuclear Medicine, Gachon University Gil Hospital)
  • 황경훈 (가천의과대학교 길병원 핵의학과) ;
  • 최덕주 (가천의과대학교 길병원 내과) ;
  • 이민경 (가천의과대학교 길병원 핵의학과) ;
  • 최원식 (가천의과대학교 길병원 핵의학과)
  • Published : 2008.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Adrenal tumors are increasingly detected by widespread use of anatomical imaging such as a, MRI, etc. For these adrenal tumors, differentiation between malignancy and benignancy is very important. In diagnostic assessment of adrenal tumor, $^{18}F-FDG$ PET and PET-CT have been reported to have high diagnostic performance, especially, very excellent performance in evaluation of adrenal metastasis in the oncologic patient. In cases of adrenal incidentalomas, $^{18}F-FDG$ PET or PET-CT is helpful if a or chemical-shift MRI is inconclusive. $^{18}F-FDG$ PET and PET-CT may be applied to the patients with MIBG-negative pheochromocytomas. In summary, $^{18}F-FDG$ PET and PET-CT are expected to be effective diagnostic tools in the management of adrenal tumor.

Keywords